Sphingosine-1-phosphate is involved in the occlusive arteriopathy of pulmonary arterial hypertension.
Despite several advances in the pathobiology of pulmonary arterial hypertension (PAH), its pathogenesis is not completely understood. Current therapy improves symptoms but has disappointing effects on survival. Sphingosine-1-phosphate (S1P) is a lysophospholipid synthesized by sphingosine kinase 1 (SphK1) and SphK2. Considering the regulatory roles of S1P in several tissues leading to vasoconstriction, inflammation, proliferation, and fibrosis, we investigated whether S1P plays a role in the pathogenesis of PAH. To test this hypothesis, we used plasma samples and lung tissue from patients with idiopathic PAH (IPAH) and the Sugen5416/hypoxia/normoxia rat model of occlusive PAH. Our study revealed an increase in the plasma concentration of S1P in patients with IPAH and in early and late stages of PAH in rats. We observed increased expression of both SphK1 and SphK2 in the remodeled pulmonary arteries of patients with IPAH and PAH rats. Exogenous S1P stimulated the proliferation of cultured rat pulmonary arterial endothelial and smooth-muscle cells. We also found that 3 weeks of treatment of late-stage PAH rats with an SphK1 inhibitor reduced the increased plasma levels of S1P and the occlusive pulmonary arteriopathy. Although inhibition of SphK1 improved cardiac index and the total pulmonary artery resistance index, it did not reduce right ventricular systolic pressure or right ventricular hypertrophy. Our study supports that S1P is involved in the pathogenesis of occlusive arteriopathy in PAH and provides further evidence that S1P signaling may be a novel therapeutic target.
Departments of Internal Medicine and Pharmacology, College of Medicine, University of South Alabama, Mobile, Alabama, USA; Center for Lung Biology, College of Medicine, University of South Alabama, Mobile, Alabama, USA.
Salina
S
Gairhe
Center for Lung Biology, College of Medicine, University of South Alabama, Mobile, Alabama, USA; Department of Biochemistry, College of Medicine, University of South Alabama, Mobile, Alabama, USA.
Sachindra R
SR
Joshi
Center for Lung Biology, College of Medicine, University of South Alabama, Mobile, Alabama, USA.
Mrigendra M
MM
Bastola
Center for Lung Biology, College of Medicine, University of South Alabama, Mobile, Alabama, USA; Department of Biochemistry, College of Medicine, University of South Alabama, Mobile, Alabama, USA.
Jared M
JM
McLendon
Departments of Internal Medicine and Pharmacology, College of Medicine, University of South Alabama, Mobile, Alabama, USA; Center for Lung Biology, College of Medicine, University of South Alabama, Mobile, Alabama, USA.
Masahiko
M
Oka
Departments of Internal Medicine and Pharmacology, College of Medicine, University of South Alabama, Mobile, Alabama, USA; Center for Lung Biology, College of Medicine, University of South Alabama, Mobile, Alabama, USA.
Karen A
KA
Fagan
Departments of Internal Medicine and Pharmacology, College of Medicine, University of South Alabama, Mobile, Alabama, USA; Center for Lung Biology, College of Medicine, University of South Alabama, Mobile, Alabama, USA.
Ivan F
IF
McMurtry
S1P; cardiac; occlusive lesions; pulmonary
Am Heart J. 2003 Jul;146(1):62-8
12851609
J Clin Invest. 1998 Mar 1;101(5):927-34
9486960
J Control Release. 2015 Jul 28;210:67-75
25979327
Circ Res. 2007 Mar 30;100(6):923-9
17332430
Biochem J. 2011 Dec 15;440(3):345-53
21848514
Am J Physiol Heart Circ Physiol. 2014 Jan 15;306(2):H243-50
24240870
J Lipid Res. 2009 Apr;50 Suppl:S272-6
18987387
Anticancer Agents Med Chem. 2012 May;12(4):285-302
21864240
Am J Physiol Lung Cell Mol Physiol. 2010 Jul;299(1):L137-45
20435688
Handb Exp Pharmacol. 2013;(216):373-401
23563667
Cell Prolif. 2012 Apr;45(2):167-75
22288844
J Clin Invest. 2015 Apr;125(4):1379-87
25831442
Br J Cancer. 2006 Nov 6;95(9):1131-5
17024123
Am Heart J. 2007 Jun;153(6):1037-47
17540207
Nat Rev Cardiol. 2011 Jun 21;8(8):443-55
21691314
Cancer Biol Ther. 2011 Jan 15;11(2):138-49
21209555
J Cell Biochem. 2004 Aug 15;92(6):1075-85
15258893
Circulation. 2016 Jun 14;133(24):2447-58
27143681
Exp Physiol. 2015 Jan;100(1):95-107
25557733
Am J Respir Crit Care Med. 2012 Aug 1;186(3):261-72
22679007
FASEB J. 2001 Feb;15(2):427-38
11156958
Am J Physiol Heart Circ Physiol. 2013 Jun 15;304(12 ):H1708-18
23585128
Handb Exp Pharmacol. 2013;(216):201-26
23563658
PLoS One. 2015 Aug 28;10(8):e0134958
26317340
Am J Physiol Heart Circ Physiol. 2016 Jan 15;310(2):H250-61
26589326
FEBS J. 2013 Nov;280(21):5317-36
23638983
J Lipid Res. 2008 Jul;49(7):1388-94
18387885
Nat Rev Cancer. 2010 Jul;10(7):489-503
20555359
Nat Rev Mol Cell Biol. 2003 May;4(5):397-407
12728273
Am J Physiol Lung Cell Mol Physiol. 2012 Nov 1;303(9):L767-77
22923644
Am J Respir Cell Mol Biol. 2013 Jul;49(1):6-17
23449739
Dig Dis Sci. 2008 Apr;53(4):997-1012
18058233
Pulm Circ. 2011 Jul-Sep;1(3):399-404
22140630
J Med Chem. 2015 Feb 26;58(4):1879-99
25643074
Sci Transl Med. 2013 Aug 28;5(200):200ra117
23986401
Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):E1614-23
25829545
Am J Physiol. 1999 Jul;277(1 Pt 1):L119-26
10409238
Chest. 1998 Sep;114(3 Suppl):225S-230S
9741573
Am J Respir Crit Care Med. 2014 Nov 1;190(9):1032-43
25180446
FASEB J. 2006 Feb;20(2):386-8
16319132
Respir Res. 2009 Oct 13;10:95
19825167
Histopathology. 2012 Oct;61(4):597-609
22748137
J Allergy Clin Immunol. 2009 Nov;124(5):933-41.e1-9
19665772
Am J Respir Crit Care Med. 2011 Nov 15;184(10 ):1171-82
21868504
Biochim Biophys Acta. 2012 Feb;1823(2):439-50
22178384
Cancer Res. 2012 Feb 1;72(3):726-35
22298596
Semin Cell Dev Biol. 2004 Oct;15(5):513-20
15271296
Pharmacol Ther. 2007 Jul;115(1):84-105
17561264
J Cell Biol. 1999 Nov 1;147(3):545-58
10545499
ScientificWorldJournal. 2006 Aug 11;6:946-66
16906327
Cell Mol Biol Lett. 2009;14(3):424-41
19238330
FASEB J. 2005 Oct;19(12 ):1646-56
16195373
Respir Res. 2006 Jan 03;7:1
16390543
Am J Physiol Cell Physiol. 2016 Jun 1;310(11):C983-92
27099350
Circ Heart Fail. 2013 Jan;6(1):136-44
23152488
Circulation. 2010 Jun 29;121(25):2747-54
20547927